ZTS FY 2016 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.9B+2.6% YoY

Gross Profit

$3.1B64.3% margin

Operating Income

$1.4B28.7% margin

Net Income

$821M16.8% margin

EPS (Diluted)

$1.65

Cash Flow

Operating Cash Flow

$713M

Free Cash Flow

$497M

Stock-Based Comp.

$37M

Balance Sheet

Total Assets

$7.6B

Total Liabilities

$6.2B

Stockholders' Equity

$1.5B

Cash & Equivalents

$727M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.9B	$4.8B	+2.6%
Gross Profit	$3.1B	$3.0B	+5.9%
Operating Income	$1.4B	$1.1B	+29.8%
Net Income	$821M	$339M	+142.2%